Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 26.4% | 24.9% | 26.3% | 25.8% | 27.1% | 29.2% | 29.3% | 22.8% | 20.9% | 23.2% | 13.6% | 13.5% | 16.3% | 9.4% | 28.8% | 22.3% | 24.7% | 22.4% | 25.0% | 30.3% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 35.3%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Eli Lilly and Company have been 25.0% over the past three years, and 25.8% over the past five years.
As of today, Eli Lilly and Company's Operating Income margin is 35.3%, which is higher than industry median of 21.7%. It indicates that Eli Lilly and Company's Operating Income margin is Good.